1

Contract Biotech Investor Relations Jobs (NOW HIRING)

Director, Investor Relations

Gaithersburg, MD ยท On-site

$181.25K - $244.70K/yr

Novavax is global biotechnology company, committed to developing life-saving innovations that reach ... Lead a comprehensive investor relations strategy that clearly communicates Novavax's vision ...

Director, Investor Relations

Gaithersburg, MD ยท On-site

$181.25K - $244.70K/yr

Novavax is global biotechnology company, committed to developing life-saving innovations that reach ... Lead a comprehensive investor relations strategy that clearly communicates Novavax's vision ...

Manager, Investor Relations Hybrid / Full Time / Chesterbrook, PA At Novocure, we're working to ... Experience in healthcare, biotech, or medical device industry * Familiarity with SEC reporting and ...

Manager, Investor Relations

Manhattan, NY ยท On-site

$125K - $135K/yr

We are seeking a Manager of Investor Relations/Public Relations who will support the development of ... the investment, biotechnology/pharmaceutical, and broader public communities. * Oversee the ...

Manager, Investor Relations

Manhattan, NY ยท On-site

$125K - $135K/yr

We are seeking a Manager of Investor Relations/Public Relations who will support the development of ... the investment, biotechnology/pharmaceutical, and broader public communities. * Oversee the ...

Investor Relations Analyst

New York, NY ยท On-site

$145K - $185K/yr

Job Summary Investor Relations Analyst Initio Capital Part-time, Full-time, Contract, Temporary, Internship, Casual Hybrid | New York, NY, United States Investor Relations Analyst - Initio Capital ...

Director, Investor Relations

Waltham, MA ยท Hybrid

$188K - $235K/yr

Zenas BioPharma is seeking an accomplished Director of Investor Relations to lead the development ... biotechnology or the life sciences; experience in a publicly traded biotech company strongly ...

Investor Relations Analyst

New York, NY ยท On-site

$145K - $185K/yr

Job Summary Investor Relations Analyst Initio Capital Full-time, Part-time, Contract, Temporary, Internship, Casual Hybrid | New York, NY, United States Investor Relations Analyst - Initio Capital ...

Investor Relations Manager

New York, NY ยท Remote

$145K - $185K/yr

Job Summary Investor Relations Manager Initio Capital Full-time, Part-time, Contract, Temporary, Internship, Casual Remote | New York, NY, United States Investor Relations Manager - Initio Capital ...

Director of Investor Relations

Beltsville, MD ยท On-site

$165K - $215K/yr

... biotechnology, or closely related industry, with direct experience leading Investor Relations and Corporate Communications at a public biotechnology company Qualifications * Proven track record of ...

next page

Showing results 1-20

Contract Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do contract biotech investor relations jobs pay per year?

As of Jun 3, 2026, the average yearly pay for contract biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What are the key skills and qualifications needed to thrive as a Contract Biotech Investor Relations professional, and why are they important?

To thrive as a Contract Biotech Investor Relations professional, you need a solid background in finance, biotechnology, and communications, often supported by a relevant degree and industry experience. Familiarity with financial modeling tools, investor databases, CRM systems, and compliance platforms is typically required. Exceptional interpersonal skills, strategic thinking, and the ability to distill complex scientific concepts for diverse stakeholders are crucial soft skills in this role. These competencies are essential for building investor trust, ensuring regulatory compliance, and effectively communicating a company's value proposition to the financial community.

What are the main challenges faced by a Contract Biotech Investor Relations professional when communicating complex scientific information to investors?

A Contract Biotech Investor Relations professional often faces the challenge of translating intricate scientific data and clinical trial results into clear, compelling messages that investors can understand. Balancing technical accuracy with investor accessibility is crucial, as miscommunication can impact investor confidence and company reputation. Additionally, keeping up with rapidly evolving scientific developments and regulatory updates, while responding promptly to investor inquiries, requires strong communication and project management skills.

What are Contract Biotech Investor Relations professionals?

Contract Biotech Investor Relations professionals are specialists hired on a temporary or project basis to manage communications between biotechnology companies and their investors. They help ensure that all investor communications, financial disclosures, and company updates are clear, compliant, and strategically aligned with the company's goals. These professionals often support fundraising efforts, prepare investor materials, coordinate meetings, and handle inquiries from current or potential investors. Their expertise helps biotech companies build and maintain strong relationships with the investment community, especially during pivotal events such as clinical trial announcements or capital raises.

What is the difference between Contract Biotech Investor Relations vs Contract Biotech Communications?

AspectContract Biotech Investor RelationsContract Biotech Communications
Primary FocusManaging investor relations, financial communication, and shareholder engagementDeveloping public relations, media outreach, and brand messaging
Required SkillsFinancial analysis, investor communication, regulatory complianceMedia relations, content creation, branding strategies
Work EnvironmentCorporate offices, investor meetings, financial eventsMedia outlets, marketing agencies, corporate communications teams

Contract Biotech Investor Relations primarily focuses on managing relationships with investors and communicating financial information, while Contract Biotech Communications emphasizes public relations and brand messaging. Both roles require strong communication skills but serve different strategic purposes within biotech companies.

More about Contract Biotech Investor Relations jobs
What cities are hiring for Contract Biotech Investor Relations jobs? Cities with the most Contract Biotech Investor Relations job openings:
What are the most commonly searched types of Biotech Investor Relations jobs? The most popular types of Biotech Investor Relations jobs are:
What states have the most Contract Biotech Investor Relations jobs? States with the most job openings for Contract Biotech Investor Relations jobs include:
Infographic showing various Contract Biotech Investor Relations job openings in the United States as of May 2026, with employment types broken down into 1% As Needed, 6% Full Time, 51% Part Time, and 42% Contract. Highlights an 92% Physical, 2% Hybrid, and 6% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.
Head of Investor Relations

Head of Investor Relations

Cytokinetics

South San Francisco, CA โ€ข On-site

$269.10K - $313.95K/yr

Full-time

Posted 28 days ago


Job description

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.
The Head of Investor Relations, will serve as a key partner to the SVP of Corporate Affairs and executive leadership team. This individual will lead the strategy and execution of Cytokinetics' investor relations strategy, ensuring clear, consistent, and compelling communication of our business strategy, financial performance, and long-term value proposition to the investment community. As the company pivots from R&D to a commercial organization, this individual has the opportunity to lead the execution of a comprehensive investor relations program to communicate the company's commercial progress and success as well as our continued leadership in muscle biology research and development.
This role requires deep pharmaceutical/biotechnology investor relations experience within commercial stage organizations, strong capital markets acumen, executive presence, and the ability to operate seamlessly at both strategic and tactical levels. The ideal candidate is equally comfortable shaping narrative at the Board level and preparing detailed materials for earnings calls and investor conferences.
Key Responsibilities
Strategic Leadership
  • Develop and execute a comprehensive investor relations strategy aligned with corporate objectives and key value inflection points.
  • Serve as a trusted advisor to the executive leadership team on investor perception, market dynamics, and capital markets strategy.
  • Closely collaborate with Senior Director, Corporate Communications to shape and refine Cytokinetics' narrative to ensure clarity, differentiation, and consistency across all investor and other communications.
  • Partner cross-functionally to anticipate and communicate major milestones, including clinical, regulatory, and commercial developments.

Investor & Analyst Engagement
  • Lead engagement with buy-side and sell-side analysts, institutional investors, and key stakeholders. Build and cultivate strong relationships with current and potential new investors
  • Prepare senior leadership for earnings calls, investor conferences, non-deal roadshows, and other investor interactions.
  • Develop and draft briefing materials, Q&A documents, key messaging, and investor presentations.
  • Collaborate with Finance to monitor analyst models, reports, and shareholder base trends; provide actionable insights to executive leadership; engage with analysts to inform consensus.
  • Monitor and alert management to market trends, industry developments, competitor activity and investor sentiment; prepare proactive and reactive plans and statements/messages, including course corrections as needed.

Earnings Preparation
  • Oversee quarterly earnings process, including script preparation, messaging strategy, and coordination across Finance and Corporate Communications.
  • Ensure alignment and accuracy across SEC filings, press releases, investor decks, and website disclosures.
  • Partner with Finance and Legal to ensure compliance with disclosure regulations and best practices.

Qualifications
  • Bachelor's degree required in Finance, Accounting, Communications; and/or advanced degree preferred.
  • 12+ years of experience in investor relations, equity research, investment banking, or related capital markets roles.
  • Significant investor relations experience within the pharmaceutical or biotechnology industry is required, preferably in a publicly traded, commercial-stage company.
  • Demonstrated experience working closely with C-suite executives and senior stakeholders.
  • Strong understanding of financial and investor markets, accounting principles and regulatory requirements.
  • Strong understanding of drug development, regulatory pathways, clinical data interpretation, and commercial dynamics in biotech/pharma.
  • Exceptional written and verbal communication skills with the ability to translate complex scientific and financial information into compelling narratives.
  • Proven ability to operate strategically while also executing tactically and independently.
  • Results-oriented with proven track record for meeting or exceeding goals
  • Proven ability to maintain confidentiality, exercise judgment and discretion
  • High executive presence, sound judgment, and discretion.
  • Willingness to travel
    #LI-HYBRID

Pay Range:
In the U.S., the hiring pay range for fully qualified candidates is $269,100-$313,950 per year. The base pay actually offered will take into account internal equity and also may vary depending on the candidate's geographic region, job-related knowledge, skills, and experience among other factors.
Our employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered. If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.
Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.
Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do - all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.
Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers
Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.
Here are some ways to check for authenticity:
  • We do not conduct job interviews through non-standard text messaging applications
  • We will never request personal information such as banking details until after an official offer has been accepted and verified
  • We will never request that you purchase equipment or other items when interviewing or hiring
  • If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at talentacquisition@cytokinetics.com

Please visit our website at: www.cytokinetics.com
Cytokinetics is an Equal Opportunity Employer